PIPPI: Developing a new toolkit for predicting protein aggregation
Protein-excipient and protein-protein interactions are the driving forces behind stability or aggregation of protein biotherapeutics. Wyatt Technology is partnering with academic and industrial researchers in the European Union’s PIPPI consortium to develop deeper understanding and a rationalized approach to biopharmaceutical formulation.
Wyatt Technology Europe
The European headquarters is equipped with a state-of-the-art applications lab and highly technical staff to better serve our customers in the region. Learn how you can take advantage of the services and training programs offered by this center of excellence.
July 24, 2018
FFF 2.0: Obtaining high resolution distributions of nanoparticle size and zeta potential,
with less time, less effort and more confidence
Christoph Johann, Ph.D., Managing Director, Wyatt Technology Europe
August 21, 2018
Characterizing Protein-Nucleic Acid Interactions by Light Scattering
Sophia Kenrick, Ph.D., Senior Application Scientist, Wyatt Technology
Join us for one of our upcoming user meetings:
Light Scattering University
Check for available upcoming training dates for Light Scattering University
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.